Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer

Summary

To explore the feasibility of target biopsy of carbon nanoparticles labelled lymph node after neoadjuvant systemic therapy for cN+ breast cancer, and evaluate whether it can accurately predict axillary lymph node status after neoadjuvant systemic therapy.

Timeline

Start

2020-09-24

Primary completion

2022-12-02

Completion

2023-05-24

Drugs

Indications